Therapeutic drug monitoring for sirolimus in whole blood of organ transplants by high-performance liquid chromatography with ultraviolet detection

被引:15
作者
Campanero, MA
Cardenas, E
Sádaba, B
García-Quetglas, E
Muñoz-Juarez, MJ
Gil-Aldea, I
Pazo, D
Azanza, JR
Honorato, J
机构
[1] Univ Navarra Clin, Serv Farmacol Clin, Pamplona 31008, Navarra, Spain
[2] Wyeth Lederle, Madrid, Spain
关键词
validation; sirolimus; rapamycin; lactones; demethoxyrapamycin;
D O I
10.1016/j.chroma.2003.10.121
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We developed and validated an accurate, sensitive, precise and rapid HPLC method with UV detection for the determination of sirolimus in blood samples from renal, cardiac and hepatic transplants. This method overcomes most of the problems related to previously published assays using a narrow-bore column with base deactivated C-18 reversed phase. Whole blood samples were purified by a combination of a precipitating blood matrix with zinc sulphate and a single step liquid-liquid extraction with acetone and 1-chlorobutane. Calibration curves (range 2.5-150 ng/ml), were linear with coefficients of correlation better than 0.996. The relative standard deviation was determined to be less than 8%. The present method has also been validated by a reference laboratory (St. George's Hospital Medical School, London, UK). More of 300 clinical samples have been analysed with this method. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:265 / 273
页数:9
相关论文
共 16 条
[1]   Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection [J].
Cattaneo, D ;
Perico, N ;
Gaspari, F .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 774 (02) :187-194
[2]   Minor immunophilin binding of tacrolimus and sirolimus metabolites [J].
Davis, DL ;
Murthy, JN ;
Gallant-Haidner, H ;
Yatscoff, RW ;
Soldin, SJ .
CLINICAL BIOCHEMISTRY, 2000, 33 (01) :1-6
[3]  
French DC, 2001, CLIN CHEM, V47, P1316
[4]   Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection [J].
Holt, DW ;
Lee, T ;
Johnston, A .
CLINICAL THERAPEUTICS, 2000, 22 :B38-B48
[5]   Therapeutic drug monitoring of immunosuppressant drugs [J].
Johnston, A ;
Holt, DW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (04) :339-350
[6]   PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCIN [J].
KAHAN, BD ;
CHANG, JY ;
SEHGAL, SN .
TRANSPLANTATION, 1991, 52 (02) :185-191
[7]   Simultaneous on-line extraction and analysis of sirolimus (rapamycin) and ciclosporin in blood by liquid chromatography electrospray mass spectrometry [J].
Kirchner, GI ;
Vidal, C ;
Jacobsen, W ;
Franzke, A ;
Hallensleben, K ;
Christians, U ;
Sewing, KF .
JOURNAL OF CHROMATOGRAPHY B, 1999, 721 (02) :285-294
[8]   Clinical pharmacokinetics of sirolimus [J].
Mahalati, K ;
Kahan, BD .
CLINICAL PHARMACOKINETICS, 2001, 40 (08) :573-585
[9]   Therapeutic monitoring of sirolimus in human whole-blood samples by high-performance liquid chromatography [J].
Maleki, S ;
Graves, S ;
Becker, S ;
Horwatt, R ;
Hicks, D ;
Stroshane, RM ;
Kincaid, H .
CLINICAL THERAPEUTICS, 2000, 22 :B25-B37
[10]   The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients [J].
Murgia, MG ;
Jordan, S ;
Kahan, BD .
KIDNEY INTERNATIONAL, 1996, 49 (01) :209-216